Advertisement

Top Stories

Cell & Gene
FDA Fast-Tracks Off-the-Shelf CAR-T for Aggressive T-Cell Cancers

WashU Medicine-developed WU-CART-007 has received Breakthrough Therapy designation after early clinical results in relapsed or refractory T-cell leukemias and lymphomas.
Cell & Gene
CRISPR Therapy Raises Fetal Hemoglobin in Sickle Cell Disease

An investigational Cas12a-edited stem cell treatment sharply boosted HbF and largely eliminated vaso-occlusive crises in an early trial
Cell & Gene
New Iron-Tracking Tool Could Boost Cartilage Regeneration Therapies

MIT-led team develops rapid, non-destructive method to predict stem cell quality during manufacturing
Biopharma
Trends and Challenges in Nitrosamine Testing: Part Two – Analytical Challenges

Sample preparation, limits of detection, and structural determination – our experts return for part two to discuss the main analytical challenges associated with nitrosamines

Browse By Topic

Cell & Gene Small Molecules Biopharma Future of Pharma
Advertisement

Recommended

Advertisement

Voices in the Community

The voices driving change and progress in medicine making. Explore stories, interviews, and community highlights that inspire and inform.

power-list
Our celebration of the most inspirational and influential leaders in medicine.
Find out more
Product Image
Christine Allen

Professor, University of Toronto; Co-founder and CEO, Intrepid Labs

View Profile
Product Image
Hanns-Christian Mahler

CEO (Chief Enablement Officer) & Board Member, ten23 health

View Profile

FOYA: Celebrating Innovation in Pharma Facilities

Product Image

We interview Scott Billman, one of the judges of the ISPE Facility of the Year Awards, to learn more about the 2025 winners and the trends impacting facilities.

Read the article

Latest News

All the latest Medicine Maker articles.

Biopharma

GLP-1 Analysis: Riding the Wave of Peptide Innovation

April 9, 2026

The remarkable commercial success of GLP-1 receptor agonists is fueling investment, accelerating science, and creating new analytical challenges. Here, we outline the hurdles these peptides present, explore methods for impurity profiling and structural characterization, and consider strategies to keep pace with this fast-moving field.

12 min read

Advertisement